Sonnet BioTherapeutics Releases Virtual Investor '"What This Means" Segment

GlobeNewswire11/12 22:15

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire11/07 02:20

Gold Down Over 2%; CVS Health Shares Jump After Q3 Results

Benzinga11/07 01:47

Sonnet BioTherapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 106.9%

Benzinga11/06 22:34

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates

GlobeNewswire11/06 21:30

Top Midday Decliners

MT Newswires10/29 03:01